Insmed, Inc.
INSM Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
Revenue Breakdown
Recent trades of INSM by members of U.S. Congress
INSM Stock Insider Trading Activity
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
INSM Stock Institutional Owners
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
INSM Derivatives Institutional Owners
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by INSM's directors and management
Government lobbying spending instances
-
$50,000 Apr 18, 2019 Issue: Health Issues
-
$50,000 Jan 18, 2019 Issue: Health Issues
-
$50,000 Oct 16, 2018 Issue: Health Issues
-
$50,000 Jul 19, 2018 Issue: Health Issues
-
$50,000 Apr 19, 2018 Issue: Health Issues
-
$22,500 Jul 20, 2011 Issue: Pharmacy
-
$22,500 Apr 11, 2011 Issue: Pharmacy
-
$22,500 Jan 17, 2011 Issue: Pharmacy
-
$22,500 Oct 12, 2010 Issue: Pharmacy
-
$22,500 Jul 20, 2010 Issue: Pharmacy
-
$22,500 May 27, 2010 Issue: Pharmacy
-
$22,500 Jan 14, 2010 Issue: Pharmacy
-
$22,500 Oct 20, 2009 Issue: Pharmacy
-
$22,500 Jul 15, 2009 Issue: Pharmacy
-
$22,500 Jul 15, 2009 Issue: Pharmacy
-
$22,500 Oct 31, 2008 Issue: Pharmacy
-
$22,500 Jul 08, 2008 Issue: Pharmacy
-
$22,500 Apr 15, 2008 Issue: Pharmacy
-
$22,500 Apr 13, 2008 Issue: Pharmacy
-
$140,000 Feb 01, 2007 Issue: Health Issues
-
$160,000 Aug 08, 2006 Issue: Health Issues
-
$40,000 Feb 13, 2006 Issue: Health Issues
Estimated quarterly lobbying spending
INSM Revenue by Segment or Geography
By Segment
By Geography
INSM Income Statement
INSM Balance Sheet
INSM Cash Flow
U.S. Patents
New patents grants
-
Patent Title: Dry powder compositions of treprostinil prodrugs and methods of use thereof Jan. 21, 2025
-
Patent Title: Methods for treating pulmonary non-tuberculous mycobacterial infections Dec. 17, 2024
-
Patent Title: Methods for treating pulmonary non-tuberculous mycobacterial infections Dec. 17, 2024
-
Patent Title: Deimmunized lysostaphin and methods of use Oct. 01, 2024
-
Patent Title: Methods for treating pulmonary non-tuberculous mycobacterial infections Jun. 25, 2024
-
Patent Title: Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating lupus nephritis Jun. 04, 2024
-
Patent Title: Lipo-glycopeptide cleavable derivatives and uses thereof Jan. 02, 2024
-
Patent Title: Prostacyclin compounds, compositions and methods of use thereof Oct. 24, 2023
-
Patent Title: Dry powder compositions of treprostinil prodrugs and methods of use thereof Sep. 19, 2023
-
Patent Title: Antibodies and methods of making same May. 16, 2023
-
Patent Title: Methods for continuous manufacture of liposomal drug products Feb. 07, 2023
-
Patent Title: Dry powder compositions of treprostinil prodrugs and methods of use thereof Oct. 04, 2022
-
Patent Title: Methods for treating pulmonary non-tuberculous mycobacterial infections Sep. 20, 2022
-
Patent Title: Methods for treating pulmonary non-tuberculous mycobacterial infections Jul. 26, 2022
-
Patent Title: Methods of manufacturing treprostinil and treprostinil derivative prodrugs Oct. 19, 2021
-
Patent Title: Lipo-glycopeptide cleavable derivatives and uses thereof Jul. 27, 2021
-
Patent Title: Prostacyclin compounds, compositions and methods of use thereof May. 04, 2021
-
Patent Title: Methods for treating pulmonary non-tuberculous mycobacterial infections Nov. 10, 2020
-
Patent Title: Methods for treating pulmonary non-tuberculous mycobacterial infections Aug. 25, 2020
-
Patent Title: Methods for treating pulmonary non-tuberculous mycobacterial infections Mar. 17, 2020
-
Patent Title: Prostacyclin compounds, compositions and methods of use thereof Jan. 07, 2020
-
Patent Title: Stabilized vancomycin formulations Nov. 12, 2019
-
Patent Title: Methods for treating pulmonary non-tuberculous mycobacterial infections Sep. 03, 2019
-
Patent Title: Methods of manufacturing treprostinil and treprostinil derivative prodrugs Jul. 09, 2019
-
Patent Title: Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Jun. 25, 2019
-
Patent Title: Methods for treating pulmonary non-tuberculous mycobacterial infections Apr. 09, 2019
-
Patent Title: Methods for treating pulmonary non-tuberculous mycobacterial infections Mar. 26, 2019
-
Patent Title: Stabilized vancomycin formulations Nov. 13, 2018
-
Patent Title: Methods of treating pulmonary disorders with liposomal amikacin formulations Sep. 04, 2018
-
Patent Title: Prostacyclin compounds, compositions and methods of use thereof Jul. 03, 2018
-
Patent Title: Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods of use thereof Mar. 27, 2018
-
Patent Title: Methods for treating pulmonary non-tuberculous mycobacterial infections Feb. 20, 2018
-
Patent Title: Sustained release of antiinfectives Nov. 28, 2017
-
Patent Title: Method of treating pulmonary disorders with liposomal amikacin formulations Aug. 22, 2017
-
Patent Title: Methods of treating pulmonary disorders with liposomal amikacin formulations Aug. 08, 2017
-
Patent Title: Systems for treating pulmonary infections Feb. 14, 2017
-
Patent Title: Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Jan. 24, 2017
-
Patent Title: Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Jan. 24, 2017
-
Patent Title: Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Dec. 06, 2016
-
Patent Title: Prostacyclin compounds, compositions and methods of use thereof Oct. 18, 2016
-
Patent Title: Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Aug. 02, 2016
-
Patent Title: Method for treating pulmonary disorders with liposomal amikacin formulations May. 10, 2016
-
Patent Title: Prostacyclin compounds, compositions and methods of use thereof Feb. 09, 2016
-
Patent Title: Platinum aggregates and process for producing the same Nov. 17, 2015
-
Patent Title: Method of treating pulmonary disorders with liposomal amikacin formulations Sep. 01, 2015
-
Patent Title: Methods of treating pulmonary disorders with liposomal amikacin formulations Aug. 25, 2015
-
Patent Title: Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally Aug. 18, 2015
-
Patent Title: Sustained release of antiinfectives Aug. 12, 2014
-
Patent Title: Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Mar. 25, 2014
-
Patent Title: Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Mar. 18, 2014
Government Contracts
Federal grants, loans, and purchases
- $10,105 2025-04-09 00:00:00 Agency: Department of Veterans Affairs
- $70,738 2025-03-21 00:00:00 Agency: Department of Veterans Affairs
- $10,105 2025-02-13 00:00:00 Agency: Department of Veterans Affairs
- $0 2024-06-14 00:00:00 Agency: Department of Veterans Affairs
- $0 2024-05-21 00:00:00 Agency: Department of Veterans Affairs
- $53,550 2023-07-14 00:00:00 Agency: Department of Veterans Affairs
Government Contracts
Estimated quarterly amount awarded from public contracts
INSM News
Recent insights relating to INSM
CNBC Recommendations
Recent picks made for INSM stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in INSM
INSM Analyst Ratings
INSM Stock Forecasts
...
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
INSM Analyst Forecasts
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
Frequently Asked Questions
- Is $INSM stock a Buy, Sell, or Hold?
- What is the price target for $INSM stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
INSM Top Shareholders
|
Shareholder
|
Shares Held
|
|---|
Frequently Asked Questions
- Who owns $INSM stock?
- Who owns the most shares of $INSM stock?
- What funds own $INSM stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
INSM Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view INSM Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More